Company intelligence
Mevion Medical Systems
Proton Therapy Has Changed. Right Size. Right Technology. Right Now.
About Mevion Medical Systems
Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is privately held and based in Littleton, Massachusetts, with international offices in the United Kingdom and Japan and a joint venture in China. For more information, please visit www.mevion.com. About the MEVION S250 Series: The MEVION S250 Series is elegantly designed to deliver high-powered, efficient proton therapy treatments. Built upon the world’s only gantry-mounted proton accelerator and benefitting from Mevion’s patented direct beam technology, the MEVION S250 Series delivers on the therapeutic promise of proton therapy while enhancing beam quality, stability and uptime. The result is reduced system complexity, higher reliability and throughput, and lower capital and operating costs—making the MEVION S250 Series a compelling, financially viable solution for all cancer centers. The Series is comprised of: • MEVION S250, offering highly stable, next-generation volumetric delivery capabilities • MEVION S250i with HYPERSCAN technology, overcoming pencil beam scanning uncertainties by delivering robust Intensity Modulated Proton Therapy treatment at hyper-speed • MEVION S250mx, making proton therapy fully scalable, with two, three and four room designs that are inherently redundant and guarantee 100 percent facility uptime
Verified activity
Signals from Mevion Medical Systems
4 published signals
Presence & Recognition
Mevion Medical Systems is featured as a sponsor of the Proton Therapy Symposium hosted by Dana-Farber Cancer Institute, where Jennifer Maggiore will address the NAPT Perspective: Evidence, Policy, & Access talk on September 26, 2026.
Reported by Mevion Medical Systems
Presence & Recognition
Mevion Medical Systems is hosting a talk by Raymond Mailhot, MD, MPH on the value proposition for compact proton therapy at the Proton Therapy Symposium hosted by Dana-Farber Cancer Institute.
Reported by Mevion Medical Systems
Presence & Recognition
Mevion Medical Systems is hosting an engaging discussion on the future of upright proton therapy at the ASTRO26 symposium hosted by Dana-Farber Cancer Institute in Boston.
Reported by Mevion Medical Systems
Presence & Recognition
Mevion Medical Systems CEO Tina Tianning Yu attended the Harvard Business School Healthcare Alumni Association's Virtual Roundtable on Tuesday, 9/22, 12PM ET to explore how MedTech leaders balance clinical efficacy, patient outcomes, quality, and cost when bringing transformative technologies to market.
Reported by Mevion Medical Systems